Active Pharmaceutical Ingredients Market Business Development, SWOT Analysis and Forecast Report, 2025

1. Active Pharmaceutical Ingredients (API) Market Revenue Drivers, Growth Opportunities, Supply Chain Analysis and Forecast Research Report Till 2025 “The global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of USD 239.8 billion by 2025, with CAGR of 6.0%.” The global Active Pharmaceutical Ingredients (API) Market research report provides complete insights on industry scope, global trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready, data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global Active Pharmaceutical Ingredient (API) market size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of USD 239.8 billion by 2025, with CAGR of 6.0%. Rising prevalence of chronic diseases such as neurological diseases, cardiovascular diseases, can lead to the growth. Key Players: AbbVie, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Cipla, Inc. Merck& Co., Inc. Albemarle Corporation

2. Request free sample to get complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/active-pharmaceutical-ingredients-api-market/request- sample Growth Drivers: The key drivers can be the rising demand of efficient and rapid acting drugs and introduction of innovative drug production facility. Major key players are choosing for outsourcing the product from the developing regions such as India, Brazil and China, which also anticipated to drive the market. In addition, pharmaceutical companies face tremendous loss in terms of revenue owing to the patent expiration of blockbuster drugs. Expiration of patent results in increasing focus for development of generic versions of the molecules. The R&D investments of the company are no longer valuable after patent expiration. Thus, the API outsourcing trend in rising. Application Outlook: Cardiovascular Disease Oncology CNS & Neurological Disorders Orthopedic Disorders Endocrinology Pulmonology Gastrointestinal Disorders Nephrology Ophthalmology Regional Insights: In 2015, API market was dominated by the North America and is anticipated to retain its position in upcoming years owing to encouraging government initiatives for generic drug usage, rising R&D expenditure, and technological advancements in the drug manufacturing practices. Asia Pacific is anticipated to be the region with fastest growth owing to the increasing availability of cheap and affordable labour. Hence, key major companies are setting up their API production plants in developing countries of Asia Pacific such as China and India. Browse Related Category Research Reports @ https://blog.naver.com/tomclark

3. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Asia Pacific Global Headquarters Million Insights Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Phone: 91-20-65300184 Email: sales@millioninsights.com